Evidence map›Paper›PMID 30808764›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Marina Kniazeva, Gary Ruvkun

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. DAF-16/FOXO maintains genome integrity following genotoxic stress.bioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Intestinal helminthFrontiers in microbiology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Innate immunity in C. elegans.Current topics in developmental biology · 2021
    Review
  15. Article
  16. eLife · 2020
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marina KniazevaDepartment of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.ORCID 0000-0002-5195-9583
Gary RuvkunDepartment of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; ruvkun@molbio.mgh.harvard.edu.

Funding

CONTROL OF THE C ELEGANS LINEAGE BY HETEROCHRONIC GENESR01GM044619 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI GARY B RUVKUN · 1991 to 2026
$14.5M
GENETIC AND MOLECULAR BASIS OF LONGEVITYR01AG016636 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GARY B RUVKUN · 1999 to 2026
$12.4M
Inositol signaling in C. elegans Senescence and DiapauseR01AG043184 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI RUVKUN, GARY B · 2012 to 2021
$4.9M
NIA NIH HHS R01 AG016636NIA NIH HHS R01 AG043184NIGMS NIH HHS R01 GM044619
6 · The paper itself

Abstract

In their natural habitat of rotting fruit, the nematode

Indexed as

AnimalsCaenorhabditis elegansCell Nucleus DivisionDNA DamageEscherichia coliFruitGenomic InstabilityIntestinesMutationRhizobiumC. elegansDNA damagemicrobiotaRhizobiumROS

Identifiers

PMID30808764
PMCPMC6397575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.